Skip to main content

Table 3 Q-Score in relation to diabetes therapy

From: Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies

  

T2DM

  

T1DM

Parameter

Diet

OHA

OHA + Insulin

Insulin

Insulin

(n = 120)

(n = 513)

(n = 439)

(n = 442)

(n = 48)

Q-Score

5.1 ± 2.6

6.8 ± 3.0

8.6 ± 3.3

9.2 ± 3.4

12.7 ± 3.2

MBG (mmol/l)

6.9 ± 1.3

7.5 ± 1.6

8.0 ± 1.8

8.0 ± 1.6

8.5 ± 1.6

Range (mmol/l)

5.1 ± 2.1

6.5 ± 2.4

7.9 ± 2.7

8.5 ± 2.9

11.1 ± 2.7

tG>8.9mmol/l (h)

0.9 (0.1-3.0)

3.1 (1.1-6.5)

5.5 (2.6-10.6)

6.5 (3.2-10.3)

9.1 (5.8-12.7)

tG<3.9mmol/l (h)

0 (0–0.4)

0 (0–0.4)

0.1 (0–0.9)

0.2 (0–1.0)

0.9 (0.1-2.4)

MODD (mmol/l)

1.2 ± 0.5

1.5 ± 0.6

2.0 ± 0.9

2.1 ± 0.9

3.3 ± 1.1

  1. Data represent the mean ± SD or median (interquartile range) for each category; OHA, oral hypoglycaemic agent; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.